All News Aadi Bioscience, Inc.

Equities

AADI

US00032Q1040

Real-time Estimate Cboe BZX Other stock markets 07:29:00 01/05/2024 pm IST			5-day change	1st Jan Change
1.88 ^USD	-2.08%		+8.43%	-4.46%

13/03	Transcript : Aadi Bioscience, Inc., Q4 2023 Earnings Call, Mar 13, 2024
13/03	Earnings Flash (AADI) AADI BIOSCIENCE Posts Q4 Revenue $6.3M	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aadi Bioscience to Report First Quarter 2024 Results and Corporate Update	05:33pm	PR
Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research Annual Meeting	10/04	AQ
Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)	17/03	PR
Transcript : Aadi Bioscience, Inc., Q4 2023 Earnings Call, Mar 13, 2024	13/03
Earnings Flash (AADI) AADI BIOSCIENCE Posts Q4 Revenue $6.3M	13/03	MT
Aadi Bioscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	13/03	CI
Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Update	13/03	PR
North American Morning Briefing : Stock Futures -2-	13/03	DJ
Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update	06/03	PR
North American Morning Briefing : Stock Futures Hover At Start of Busy Week	04/03	DJ
Aadi Bioscience Reports Supportive Data from Tumor Treatment Trial -- Shares Jump After Hours	02/03	MT
Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa	02/03	PR
Aadi Bioscience to Present at the TD Cowen 44th Annual Healthcare Conference	27/02	PR
North American Morning Briefing : Stock Futures -2-	18/12	DJ
Sector Update: Health Care Stocks Retreating Late Afternoon	16/12	MT
Top Midday Decliners	16/12	MT
Piper Sandler Cuts Aadi Bioscience's Price Target to $5 From $30, Keeps Overweight Rating	15/12	MT
Wall Street Set to Open Narrowly Mixed Ahead of PMI, Industrial Production Data	15/12	MT
Top Premarket Decliners	15/12	MT
HC Wainwright Downgrades Aadi Bioscience to Neutral From Buy	15/12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Aadi Bioscience, Inc.

Equities

AADI

US00032Q1040

All News

Filters